Cystic fibrosis: the delta F508 mutation does not lead to an exceptionally severe phenotype. A cohort study

G Borgo1, P Gasparini, A Bonizzato

  • 1Centro Regionale Veneto Fibrosi Cistica, Ospedale Civile Maggiore, Verona, Italy.

Insights

The delta F508 mutation in cystic fibrosis (CF) does not appear to affect lung or nutritional status in children aged 8.5-10 years. This finding suggests genotype-phenotype correlations in CF may not be evident at this early age.

Area of Science:

  • Genetics
  • Pediatrics
  • Pulmonology

Background:

  • Cystic Fibrosis (CF) is a genetic disorder affecting multiple organs.
  • Understanding genotype-phenotype relationships is crucial for predicting disease progression and tailoring treatments.
  • The delta F508 mutation is the most common CF-causing mutation worldwide.

Purpose of the Study:

  • To investigate the relationship between specific genotypes and the clinical presentation of cystic fibrosis.
  • To assess pulmonary and nutritional status in relation to the delta F508 mutation in young CF patients.

Main Methods:

  • A cohort of 123 pediatric cystic fibrosis patients (aged 8.5-10 years) with known genotypes was studied.
  • Patients were followed at a single center with standardized diagnostic and treatment protocols.
  • Pulmonary function and nutritional markers were assessed and compared across different genotype groups.

Main Results:

  • No significant differences in pulmonary status or nutritional deficiencies were observed between patients homozygous for the delta F508 mutation and those with other genotypes (compound heterozygotes or unspecified).
  • Wide variability in pulmonary manifestations was noted across all genotype groups.
  • A potential slight increase in mortality among delta F508 homozygotes was considered coincidental given the sample size.

Conclusions:

  • In children with cystic fibrosis up to age 10, the severity of lung disease and nutritional status is not directly correlated with the delta F508 mutation.
  • Early-onset genotype-phenotype correlations in cystic fibrosis may be less pronounced than previously thought or influenced by other factors.

Related Concept Videos

Mutations02:27

Mutations

Mutations are changes in the sequence of DNA. These changes can occur spontaneously during DNA replication or be induced by environmental factors. Mutations can be characterized in several ways: by whether and how they alter the amino acid sequence of the protein, by the scale of the DNA affected, and by whether they affect somatic or germline cells.Consequences of Point Mutations at the Molecular LevelMutations that affect a single nucleotide are called point mutations. When point mutations...
Incomplete Dominance01:43

Incomplete Dominance

Gregor Mendel's work (1822 - 1884) was primarily focused on pea plants. Through his initial experiments, he determined that every gene in a diploid cell has two variants called alleles inherited from each parent. He suggested that amongst these two alleles, one allele is dominant in character and the other recessive. The combination of alleles determines the phenotype of a gene in an organism.
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...